Skip to main content

Table 2 Correlation between drug resistance identified by MLPA and GenoTypeMTBDR plus

From: Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates

 

Drug resistance by GenoTypeMTBDRplus

Drug resistance by MLPA

rpoBWT

rpoBMUT3

rpoBMUT othera

katGWT

katGMUT1

katGMUT otherb

inhAWT

inhAMUT1

inhAMUT1 and katGMUT1

No result

no rpoB mutation

76

0

3

      

2

intermediate rpoB

6

1

0

      

1

rpoB-S531L (rpoBMUT3)

0

11

0

      

0

rpoB-S522L

1

0

0

      

0

no katG mutation

   

74

0

0

   

1

katG-S315T (katGMUT1)

   

0

14

1

   

1

intermediate katG

   

1

0

0

   

0

no inhA mutation

      

64

0

0

2

inhA-15 C/T (inhAMUT1)

      

6

2

0

0

inhAMUT1 and katGMUT1

      

0

0

5

1

intermediate inhA

      

5

0

0

0

Total isolates (GenoTypeMTBDRplus)

82

12

3

75

14

1

75

2

5

3

  1. Mutations obtained by MLPA are indicated for the respective genetic marker investigated with the GenoTypeMTBDRplus assay; isolates for which no results were obtained by GenoTypeMTBDRplus MLPA results for all genetic markers are indicated; an intermediate result indicates the presence of an intermediate signal and thus no presence or absence for the respective genetic marker; a = two isolates did not show a positive band with the rpoBWT8 probe but no mutation probe was positive; one isolate did not show a positive band for the rpoBWT3 and rpoBWT4. b = one isolate did not show a positive band with the katGWT1 probe but no mutation probe was identified.